Mkts

Karyopharm Therapeutics Inc.

NASDAQ: KPTI
$0.06+0.00 (-8.33%)
As of Nov 6, 9:30 AM ET

Key statistics

Day range
0.040.06
52-week range
0.0410.99
Today
Open0.05
Previous close0.06
Volume103.75M
Valuation
Market cap12.39M
P/E ratio—
EPS (TTM)-12.84
Income & risk
Dividend / yield—
Beta1.17
Avg volume29.58M
Discussion

KPTI News

Stories mentioning KPTI from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue35,06634,07944,04437,92930,01530,54238,78342,786
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development33,79727,66730,54432,78834,61833,30236,13438,371
Sales General & Admin26,68422,77226,60728,47727,35227,19027,63231,070
Total Operating Expenses61,82651,92359,26462,31663,27161,82365,06670,906
Operating Income (Loss)(26,760)(17,844)(15,220)(24,387)(33,256)(31,281)(26,283)(28,120)
Interest Income511.00607.00553.00613.001,0001,4821,8321,930
Interest Expense8,949
Other Expense16,411(10,044)(7,418)(2,210)19,82410,1143,79214,296
Pretax Income(22,391)(102,265)(33,093)(37,212)(23,426)(30,889)(32,044)23,859
Tax Provision1.00(67.00)34.0040.0036.00(109.00)28.0067.00
Net Income (Loss)(22,392)(102,198)(33,127)(37,252)(23,462)(30,780)(32,072)23,792
Earnings Per Share (Basic)(1.02)(9,291)(3.82)(4.32)(2.77)(3,848)(3.85)2.26
Earnings Per Share (Diluted)(1.24)(9,291)(3.82)(4.32)(2.77)(3,848)(3.85)(2.97)
Weighted Average Shares Outstanding (Basic)22.0011.009.009.008.008.008.008.00
Weighted Average Shares Outstanding (Diluted)25.0011.009.009.008.008.008.0010.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About KPTI

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) is a stock listed on the Nasdaq Stock Market under the ticker symbol KPTI. It last traded at $0.0600 (Nov 6, 2026, 9:30 AM ET), down 8.3% on the day. That gives Karyopharm Therapeutics a market capitalisation of $12.4M.

Over the past 52 weeks KPTI has traded between $0.0400 and $10.99.

Revenue for the quarter ended Mar 31, 2026 was $35.1M; a net loss of $22.4M. Revenue was up 16.8% from $30.0M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$35.1M-$22.4M-63.9%
Dec 31, 2025$34.1M-$102.2M-299.9%
Sep 30, 2025$44.0M-$33.1M-75.2%
Jun 30, 2025$37.9M-$37.3M-98.2%

From Karyopharm Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…